Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorSecond Affiliated Hospital of Nanchang University

About this trial

The LD-ITUK is a multicenter, prospective, randomized, double-blind, blind endpoint, placebo-control design trial. All eligible patients with the diagnosis of severe aSAH will be randomly assigned to the treatment group or the placebo group. Patients in the treatment group will receive standard treatment with the addition of lumbar drainage combined with intrathecal urokinase injection started within 24 hours after aneurysm treatment with 30000 IU urokinase, once a day for 3 consecutive days. Patients in the control group will receive standard treatment with the addition of lumbar drainage combined with intrathecal placebo (0.9%NaCl) injection. The primary outcome measure is favorable functional outcome, defined as a score of 0 to 2 on the modified Rankin Scale (mRS), at 6 months after aneurysmal SAH. Primary outcome will be determined by a member of the Independent Committee on Terminal events.

Eligibility criteria

Qualifiers

Patient's age ≥ 18 years

First occurrence of aneurysmal subarachnoid hemorrhage

Patients without any craniotomy treatment before onset

Hunt-Hess grade III-V

Disqualifiers

Subarachnoid hemorrhage caused by arteriovenous malformation or moyamoya disease or other cerebrovascular disease

Patients requiring craniotomy to remove intracranial hematoma

modified Fisher Scale grade 0

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are greater than 2 times the extended range

Trial design

Treatments tested in this trial

  • Urokinase
  • Placebo

Treatment groups

424 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Second Affiliated Hospital of Nanchang University

Lead sponsor

First Affiliated Hospital of Fujian Medical University

Collaborator

Huashan Hospital

Collaborator

Henan Provincial People's Hospital

Collaborator

Tongji Hospital

Collaborator

Southern Medical University, China

Collaborator

Qilu Hospital of Shandong University

Collaborator

Sichuan Provincial People's Hospital

Collaborator

Zhongnan Hospital

Collaborator

Zhejiang University

Collaborator

The First Affiliated Hospital of Zhengzhou University

Collaborator

Xiangya Hospital of Central South University

Collaborator

First Affiliated Hospital of Gannan Medical University

Collaborator

Ganzhou City People's Hospital

Collaborator

The First Affiliated Hospital of Anhui Medical University

Collaborator

Renmin Hospital of Wuhan University

Collaborator

First Affiliated Hospital of Harbin Medical University

Collaborator

The Second Affiliated Hospital of Harbin Medical University

Collaborator

Yichang Central People's Hospital

Collaborator

Xianning Central Hospital

Collaborator

Linyi People's Hospital

Collaborator

Panzhihua Central Hospital

Collaborator

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Collaborator

The Second Military Medical University Changhai Hospital

Collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborator

The First Affiliated Hospital with Nanjing Medical University

Collaborator

904th Hospital of the Joint Logistics Support Force of the PLA

Collaborator

Qianfoshan Hospital

Collaborator

Dezhou Hospital Qilu Hospital of Shandong University

Collaborator

Liaocheng People's Hospital

Collaborator

Xuanwu Hospital, Beijing

Collaborator

Jiujiang No.1 People's Hospital

Collaborator

The First People's Hospital of Changde City

Collaborator